MUMBAI, 1st DECEMBER, 2024 (GPN): Dr. L H Hiranandani Hospital, a renowned multi-specialty institution in Powai, Mumbai, has marked a ground-breaking achievement by successfully treating and discharging its first patient with relapsed refractory lymphoma using CAR-T Cell therapy. This innovative and advanced treatment positions the hospital among the premier oncology centers offering CAR-T Cell therapy for relapsed and refractory B-Cell lymphoma. Notably, this is only the third such successful treatment in Mumbai, highlighting the city’s growing prominence in cutting-edge cancer care.

About CAR-T Cell Therapy :

CAR-T (Chimeric Antigen Receptor T-cell) therapy is a cutting-edge cancer treatment that reprograms a patient’s immune cells to target and destroy cancer cells. The process involves extracting T cells from the patient’s blood, genetically modifying them in a laboratory to express CARs capable of recognizing cancer cells, and re-infusing them into the patient .CAR-T therapy is a targeted, minimally invasive treatment modality which offers improved clinical outcomes This personalized treatment leverages the body’s immune system, offering a highly precise and effective approach to battling specific blood cancers, including leukemia, lymphoma, and multiple myeloma.

CAR-T cell therapy is designed to be a one-time treatment, as the modified T cells can remain active in the body for an extended period, providing long-lasting protection. This revolutionary therapy represents a major leap forward in oncology care, offering renewed hope to patients battling previously untreatable blood cancers.

A New Era in Cancer Treatment

The success of this therapy at Dr. L H Hiranandani Hospital underscores the hospital’s commitment to advancing medical innovation and delivering world-class care. By harnessing the power of immunotherapy, the hospital is helping shape a new era in oncology, offering patients and their families a beacon of hope in the fight against cancer.

As the medical community celebrates this remarkable achievement, the hospital remains dedicated to pushing the boundaries of cancer treatment and transforming lives through ground-breaking therapies.

Let us celebrate this significant step forward for Mumbai and the global healthcare community, as we continue to pave the way for revolutionary advances in cancer care.